Abstract The aim of the present study was to determine the changes in phospholamban protein levels and their regulatory effect on sarcoplasmic reticulum (SR) Ca2+ uptake and left ventricular function in hypothyroid and hyperthyroid rat hearts. Hypothyroidism was associated with decreases in basal left ventricular function (+dP/dt and -dP/dt), whereas in hyperthyroidism these parameters were elevated compared with values for euthyroid hearts. (3-adrenergic agonists. (Circ Res. 1994;75:245-251.) 
Abstract The aim of the present study was to determine the changes in phospholamban protein levels and their regulatory effect on sarcoplasmic reticulum (SR) Ca2+ uptake and left ventricular function in hypothyroid and hyperthyroid rat hearts. Hypothyroidism was associated with decreases in basal left ventricular function (+dP/dt and -dP/dt), whereas in hyperthyroidism these parameters were elevated compared with values for euthyroid hearts. The maximal SR Ca> uptake rates were 12.8+1.1, 15 .5±1.2, and 21.4±1.4 nmol Ca2+ per milligram per minute, and the EC50 values for Ca2+ were 0.76±0.09, 0.41±0.07, and 0.30±0.05 gmol/L assayed in homogenates from hypothyroid, euthyroid, and hyperthyroid hearts, respectively. The relative tissue level of phospholamban was increased (135%) in hypothyroidism and decreased (75%) in hyperthyroidism compared with euthyroidism (100%). An opposite trend was observed for the SR Ca>2-ATPase, which was depressed (74%) in hypothyroid hearts but increased (134%) in hyperthyroid hearts. Consequently, the emodynamic alterations that are associated with various thyroid states have been the subject of several investigations. Increases in oxygen consumption, heart rate, cardiac output, left ventricular contractility, and relaxation velocity were reported to occur in hyperthyroidism, whereas decreases in these parameters were found in hypothyroidism.1-3The mechanisms for these changes have been suggested to include alterations in the expression and/or activity levels of various proteins. Hyperthyroidism was shown to activate the a-myosin heavy chain gene expression (V1) and repress the ,B-myosin heavy chain gene expression (V3), resulting in an increase in the V1 isoform.45 On the other hand, the V3 isoform predominates in the hypothyroid state. Thyroid hormones have also been shown to regulate the expression and/or activity of the dihydropyridine-sensitive slow Ca2+ channels,6 the sarcolemmal Ca2+-ATPase,7 the density of f3-receptors,8 and the guanine nucleotide-binding regulatory protein.9 All these cellular alterations may be associated with changes in Ca>2 transients, which may lead to alterations in cardiac functional parameters. However, the most important regulator of Ca2+ homeostasis is the sarcoplasmic reticulum (SR), which serves as a sink for Ca2+ ions during relaxation and as a Ca>2 source during contraction. The important proteins in the SR membrane are the ryanodine receptor (which is involved in the release of Ca2+ from the SR), the Ca2+-ATPase (which mediates the uptake of Ca2+ from the cytosol during muscle relaxation), and phospholamban (the regulator of the SR Ca2+-ATPase). Phospholamban has been shown to be phosphorylated in vitro by various kinases at distinct sites.10-12 The dephosphorylated form of phospholamban has been suggested to inhibit the SR Ca2+-ATPase through a decrease in the affinity of the enzyme for Ca2+, and phosphorylation of phospholamban relieves the inhibition.11 Phospholamban has also been found to be phosphorylated in intact beating hearts on isoproterenol stimulation. Increases in 32p incorporation into phospholamban were associated with elevated rates of Ca2+ uptake into SR membrane vesicles and SR Ca2+-ATPase activity. 13 reperfusion, the circuit was returned to the drip-through system with nonradioactive Krebs' solution. After a short washout period, the hearts were stimulated with 0.1 ,umol/L isoproterenol for various times. After the stimulation, the preparations were freeze-clamped (-196°C), powdered, and stored under liquid nitrogen, as described previously. 20 The left ventricular pressure, its first derivative (dP/dt), and the spontaneous heart rate were continuously monitored through a pressure transducer attached to a computer system. Ratecorrected values for maximal rate of contractility (+dP/dt) and relaxation (-dP/dt) of the isoproterenol-stimulated hypothyroid and euthyroid rat hearts were calculated by using a computer program that subtracted the changes in these contractile parameters caused by changes in heart rate. 21 The computer program used calibration curves based on the relation between changes in -dP/dt and +dP/dt values of perfused hypothyroid and euthyroid rat hearts, which were due to changes in the heart rate elicited by pacing the hearts at various frequencies (180 to 300 beats per minute). The ratecorrected values for +dP/dt and -dP/dt in hypothyroid and euthyroid hearts are reported here. There were no significant increases in the heart rate of hyperthyroid hearts perfused by isoproterenol in the present study; consequently, no rate correction was performed in these hearts.
In parallel studies, hearts were perfused with nonradioactive Krebs' buffer under conditions identical to those described above, and these hearts were used for assessment of their hemodynamic characteristics and cAMP levels. 
Results

Effects of Various Thyroid States on SR Function
Hyperthyroidism was associated with significant increases in the ratio of heart weight to body weight and cardiac myofibrillar and SR Ca2+-ATPase activities when compared with euthyroidism (Table 1) . On the other hand, hypothyroidism resulted in lower ratios of heart weight to body weight and myofibrillar and SR Ca2+-ATPase activities when compared with euthyroidism. No significant changes were noted in the basal cAMP tissue levels among the various groups. The hypothyroid state in these animals was confirmed by serum-free T3 analysis: 9.2±1.8 pmol/L (n=5) in control rats compared with 2.3±1.3 pmol/L (n=4) in hypothyroid rats.
Initial rates of ATP-dependent oxalate-facilitated Ca 2+ uptake were obtained in cardiac homogenates from different thyroid states assayed at various Ca21 concentrations (Fig 1) hearts (Fig 3, Table 2 ). On the other hand, in hypothyroid animals the expression of the SR Ca2+-ATPase was depressed. Examination of the phospholamban levels in the same hearts revealed an opposite trend in the expression of this protein compared with the SR Ca'-ATPase. There was a significant decrease in the phospholamban levels in the hyperthyroid hearts and an increase in the hypothyroid hearts compared with euthyroid hearts (Fig 3) . Table 2 summarizes the data obtained with six different hearts from each group. The relative ratios of the binding sites for PHL-Ab and SRCA-Ab, which reflect the relative levels of these proteins in the same hearts, were estimated from the quantitative immunoblots and are presented as the ratio of phospholamban to Ca2 -ATPase (Table 2 ). This relative ratio of phospholamban to Ca2'-ATPase was observed to increase in hypothyroid rats, whereas it Fig 3) and applied on duplicate gels. SR Ca2+-ATPase and PLB protein levels were determined by quantitative immunoblotting (Fig 3) decreased in hyperthyroid rats compared with euthyroid rats. These changes appeared to be significant in both conditions. When the changes in the relative ratios of phospholamban to Ca2'-ATPase were plotted against the changes in EC50 values of SR Ca2' uptake for Ca2' in hypothyroid, euthyroid, and hyperthyroid hearts, a close significant correlation was observed (Fig 1, inset) .
Effects of Various Thyroid States on Left Ventricular Function and Kinetics of Phospholamban Phosphorylation
To examine the functional consequences of the thyroid hormone-induced changes in phospholamban and Ca2'-ATPase levels, hearts from hypothyroid, euthyroid, and hyperthyroid rats were perfused and stimulated with 0.1 ,umol/L isoproterenol. This concentration of isoproterenol resulted in maximal hemodynamic responses in all hearts with different thyroid conditions (data not shown). At basal (nonstimulated) conditions, both +dP/dt and -dP/dt were significantly higher in hearts from hyperthyroid rats but lower in hearts from hypothyroid rats compared with euthyroid rats (Table  1) . Examination of the basal heart rate revealed that this parameter was significantly increased in hyperthyroid compared with hypothyroid or euthyroid hearts. On isoproterenol perfusion, both cardiac inotropy (+dP/dt) and the speed of relaxation (-dP/dt) were significantly increased in hypothyroid and euthyroid hearts. In hyperthyroid hearts, increases were noted only in the -dP/dt values, and these became significant after 1.5 minutes of isoproterenol perfusion (Figs 4 and 5) . When the maximal increases in the speed of relaxation after isoproterenol stimulation were plotted against the relative ratios of phospholamban to Ca2'-ATPase (Table   2) , there was a close correlation observed (Fig 5, inset) .
To determine the kinetics of 32p incorporation into phospholamban and the relation between its phosphorylation and cardiac function, hearts from hypothyroid, euthyroid, and hyperthyroid rats were perfused with [32P]orthophosphate-labeled Krebs' buffer and stimulated with 0.1 ,tmol/L isoproterenol for various times (Fig 6) . In the absence of isoproterenol, there were no significant differences in the 32p label associated with phospholamban between the hypothyroid, euthyroid, and hyperthyroid hearts, although the levels of phospholamban were different among these groups ( Table   2 ). The lack of observed differences in the extent of 32p label into phospholamban in these hearts may reflect alterations in the levels or the interplay of cardiac protein kinases and phosphatases by thyroid hormone levels. After (Fig 6) . These observations in beating hearts are in agreement with our findings on the relative amounts of phospholamban (Table 2) in the hypothyroid and hyperthyroid hearts. When the changes in 32p incorporation into phospholamban were plotted against the changes in the maximal speed of relaxation after isoproterenol treatment, a significant correlation was observed for all three groups (Fig 7) . Examination of the regression lines revealed that the relaxant effect of isoproterenol was the highest in hypothyroid and the lowest in hyperthyroid hearts, consistent with the levels of phospholamban present in these hearts (Table 2) .
Discussion
In the present study, using quantitative immunoblotting, we demonstrate that the functional changes in the hypothyroid and hyperthyroid rat hearts were associated with alterations in the levels of phospholamban and the SR Ca2+-ATPase. In previous studies, it was shown that the steady-state mRNA levels of SR Ca>2-ATPase decreased in hypothyroidism and, conversely, that these levels were increased in hyperthyroidism. 16 On the other hand, in hypothyroidism the SR Ca2+ uptake and the myocardial relaxation rate were depressed as a consequence of downregulation of Ca 2+-ATPase gene expression and overexpression of its inhibitor, phospholamban. Under this thyroid condition, the phospholamban inhibitory effect on the SR Ca2+-ATPase activity was fully reversed on isoproterenol stimulation, and the speed of relaxation was similar to that present in euthyroid hearts. These findings are consistent with clinical observations on the different levels of sensitivity of hyperthyroid and hypothyroid patients to fl-agonists.32 In the present study, a close correlation between the maximal increases of left ventricular relaxation, elicited by isoproterenol, and the relative ratios of phospholamban to Ca2+-ATPase was obtained in hypothyroid, euthyroid, and hyperthyroid rats. This finding suggests that the amount of phospholamban in relation to SR Ca 2+_ ATPase is an important determinant of the speed of relaxation.
In summary, our data indicate that thyroid hormones have an inverse effect on phospholamban and the SR Ca2+-ATPase protein levels in the heart. The changes in these proteins would explain, at least in part, the alterations in (1) SR Ca2+ uptake rates, (2) the affinity of the SR Ca pump for Ca , (3) the speed of myocardial relaxation, and (4) the stimulation of relaxation rates by ,3-adrenergic agonists observed in hypothyroid and hyperthyroid hearts. Future studies using transgenic animal models may be designed to fully elucidate the role of phospholamban in the regulation of SR function and myocardial contractility in different thyroid conditions. 
